FIELD OF APPLICATION DETAILS
Generic Name
Norethynodrel
Active Ingredient
Norethynodrel
US Brand Names
Enovid, Enovid-E
Drug Category
Gynecology
Drug Class
Palliative treatment, Immunosuppressive therapy
Route of Administration
Oral
FDA Approval Status
Withdrawn

Norethynodrel: Overview

Norethynodrel belongs to the class of organic compounds known as oxosteroids. Chemically, it is a 19-nortestosterone-derived synthetic progestational hormone with actions similar to natural progesterone.

In the history of endocrinology and gynecology, norethynodrel holds landmark significance as the progestational component of Enovid (combined with the estrogen mestranol), which became the world’s first commercially approved oral contraceptive pill. Historically, it was utilized to treat functional uterine bleeding, severe menstrual disorders, and endometriosis. As a relatively weak progestogen compared to modern options, norethynodrel has since been superseded by newer progestins and is no longer actively marketed or used in clinical practice.

Key Facts Summary:

Norethynodrel: What Is It and How Does It Work

Norethynodrel functions as a prodrug and direct agonist at progesterone receptors, exerting strong anti-gonadotropic effects across the female reproductive system.

  • Progesterone Receptor Agonism: It binds to and activates progesterone receptors in target tissues, inducing a secretory transformation of the endometrium to stabilize the uterine lining and prevent irregular bleeding.
  • Pituitary Suppression: It exerts negative feedback on the hypothalamic-pituitary-gonadal axis, inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland, thereby halting ovulation.
  • Secondary Estrogenic Activity: Unlike many other 19-nortestosterone derivatives, norethynodrel metabolizes into compounds with weak intrinsic estrogenic activity, which contributed to cycle control when paired with mestranol in early contraceptive formulations.

Norethynodrel: FDA Approval and Uses

No. Norethynodrel is currently categorized as Withdrawn and is Not Approved for active commercial distribution. It was historically approved by the US FDA under the brand name Enovid first in June 1957 for severe menstrual disorders, and subsequently in June 1960 as the first oral contraceptive. It was later discontinued as modern progestins with superior potency and safety profiles were developed.

What Is It Used For

Historically, prior to its withdrawal, norethynodrel was indicated for the following clinical purposes:

  • Oral Contraception: Combined with mestranol to prevent pregnancy by inhibiting ovulation and altering cervical mucus.
  • Functional Uterine Bleeding: Used to manage severe, irregular menstrual bleeding and stabilize the endometrial lining.
  • Endometriosis: Administered in higher daily doses to suppress ovarian steroidogenesis and cause regression of endometriotic implants.

Before Taking Norethynodrel Contraindications and Precautions

Who Should Not Take Norethynodrel

  • Women with an active or past history of deep vein thrombosis (DVT), pulmonary embolism, stroke, or severe coronary artery disease.
  • Patients with known, suspected, or a history of estrogen- or progesterone-dependent malignancies, such as breast cancer.
  • Individuals with severe hepatic impairment, active liver disease, or liver tumors.
  • Women with undiagnosed abnormal genital bleeding.

Norethynodrel: Pregnancy and Breastfeeding

Norethynodrel is strictly contraindicated during pregnancy. Early historical use during threatened miscarriages revealed rare risks of virilization in female fetuses due to androgenic metabolites. While small amounts of progestins pass into breast milk, it is generally contraindicated in nursing mothers because synthetic hormones can reduce the quantity and quality of milk production.

Tell Your Doctor Before Taking Norethynodrel

In a historical clinical context, patients were required to inform their physician of any history of severe hypertension, gallbladder disease, depression, diabetes, or familial clotting disorders before starting therapy.

Norethynodrel: Dosage and Administration

Standard Norethynodrel Dosing

Dosing varied based on the historical indication being treated.

  • Contraception (Historical): Administered as a combination pill containing 9.85 mg (later reduced to 5 mg and 2.5 mg) of norethynodrel with mestranol, taken orally once daily for 20 or 21 days of a menstrual cycle.
  • Endometriosis (Historical): High doses ranging from 20 mg up to 100 mg daily were given continuously to suppress menstruation.

How Norethynodrel Was Administered

  • Dosage Forms: Supplied historically as oral Tablets.
  • Administration Routes: Administered via the Oral route.

Norethynodrel Side Effects and Safety Profile

BLACK BOX WARNING

Carried the class-wide Boxed Warning for oral contraceptives: Cigarette Smoking and Serious Cardiovascular Events. Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age (particularly in women over 35 years of age) and with the number of cigarettes smoked. Combined oral contraceptives are contraindicated in women over 35 who smoke.

The safety profile of high-dose early progestins like norethynodrel carried substantial systemic risks. Because it was developed in early endocrine research, its high active doses frequently caused central nervous system, metabolic, and vascular complications.

Common Side Effects

  • Nausea, vomiting, and abdominal bloating.
  • Breakthrough bleeding, spotting, and changes in menstrual flow.
  • Weight gain, fluid retention, and edema.
  • Breast swelling and tenderness.
  • Headaches and mood changes.

Serious Adverse Events

  • Thromboembolic Events: Significantly elevated risk of deep vein thrombosis (DVT) and fatal pulmonary embolism.
  • Cerebrovascular Accidents: Increased risk of ischemic stroke and heart attack, particularly in women who smoke.
  • Hepatic Neoplasms: Rare development of benign or malignant liver tumors.

Managing Side Effects

In historical practice, if severe side effects such as chest pain, shortness of breath, severe calf pain, or sudden visual disturbances occurred, the drug was stopped immediately, and emergency care was initiated.

Norethynodrel: Drug Interactions and What to Avoid

Key Norethynodrel Interactions

Norethynodrel is metabolized by cytochrome P450 enzymes in the liver (CYP3A4):

  • CYP3A4 Inducers: Drugs like rifampin, carbamazepine, and St. John’s Wort accelerate its hepatic metabolism, potentially causing contraceptive failure and severe breakthrough bleeding.
  • Anticoagulants: Synthetic progestins and estrogens alter hepatic clotting factor synthesis, interfering with blood thinners like warfarin.

Norethynodrel: Food and Alcohol

Taking oral doses with food helped reduce severe early nausea. Smoking cigarettes while taking synthetic hormonal contraceptives exponentially increased the risk of stroke and fatal blood clots.

Norethynodrel: Missed Dose, Overdose and Storage

Missed Dose of Norethynodrel

In historical contraceptive regimens, if a daily pill was missed, patients were instructed to take it as soon as remembered; missing multiple pills drastically increased the risk of breakthrough ovulation and pregnancy.

Norethynodrel: Overdose

An acute overdose typically caused severe nausea, vomiting, breast enlargement, and subsequent withdrawal bleeding in females. Management was purely supportive.

How to Store Norethynodrel

Historical tablet formulations were stored at controlled room temperature, protected from excess heat, light, and moisture.

Norethynodrel: Patient Management and Guidelines

Tests Before and During Norethynodrel Treatment

  • Baseline Physical Exam: Comprehensive pelvic exam, blood pressure check, and breast exam prior to starting therapy.
  • Blood Pressure Monitoring: Routine checks to screen for hormone-induced hypertension.

Norethynodrel: Do’s and Don’ts

  • Do recognize that norethynodrel is a discontinued legacy drug that is no longer available or prescribed in modern medicine.
  • Do consult a gynecologist for modern, low-dose oral contraceptives with significantly lower side effect profiles.
  • Do not smoke while taking any systemic combination hormonal contraceptive.

Frequently Asked Questions

What was Norethynodrel used for?

It was a synthetic progestin historically used in the first birth control pills (Enovid) to prevent pregnancy and manage gynecological conditions such as functional uterine bleeding and endometriosis.

Is Norethynodrel still FDA approved?

No. While it was historically approved in 1957 for menstrual disorders and in 1960 for contraception, it has been discontinued and withdrawn from the market. It is no longer approved for clinical use.

What was Enovid?

Enovid was the brand name of the world’s first FDA-approved oral contraceptive pill, which contained a combination of the synthetic progestin norethynodrel and the synthetic estrogen mestranol.

Why is Norethynodrel no longer used today?

It was phased out because it was a relatively weak progestogen that required very high daily doses to be effective. Modern oral contraceptives utilize much lower doses of modern, highly potent progestins with significantly better safety profiles.

What were the primary side effects and health risks associated with Norethynodrel?

Common side effects included severe nausea, bloating, fluid retention, weight gain, and breakthrough bleeding. Serious health risks included deep vein thrombosis (DVT), pulmonary embolism, high blood pressure, stroke, and liver tumors.

Does Norethynodrel have any androgenic or male hormone effects?

Unlike many other early 19-nortestosterone derivatives, norethynodrel has minimal androgenic activity and exhibits weak intrinsic estrogenic properties, which helped control menstrual cycles when combined with estrogen.

Can Norethynodrel be taken during pregnancy or while breastfeeding?

No. It is strictly contraindicated during pregnancy due to the risk of fetal harm. It is also not recommended while breastfeeding because synthetic hormones can reduce both the quantity and quality of breast milk.

References

  • DrugBank Database Norethynodrel Clinical and Pharmacological Profile
  • US Food and Drug Administration Historical Archives on Enovid Approval
  • Historical Gynecological Literature on Early Oral Contraceptive Development

The information provided is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding medical conditions or treatment plans.